PubMed · 11633650
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
P Borisov. 1975. [Not Available].. https://pubmed.ncbi.nlm.nih.gov/11633650/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
The effects of thermal water from Cserkeszölö in Hungary were appraised in a randomised, double blind study conducted on 58 patients with osteoarthritis of the knee. Balneotherapy was delivered as a 15-day course of 30-min daily sessions performed with thermal water (active treatment) or tap water of similar colour and odour (placebo treatment). The musculoskeletal status of participants was evaluated at baseline, at the end of the balneotherapy course, and 3 months later. Study endpoints (initial pain, range of motion, tenderness on palpation, stair climbing, physicians' opinion and subjective rating by patients, and ambulation) were assessed using visual analogue scales and symptom scores. Both groups improved; however, the magnitude of improvement was significantly greater in patients treated with thermal water from Cserkeszölö.
AIM: To study effectiveness of short courses of intensive peloidobalneotherapy in duodenal ulcer (DU). MATERIAL AND METHODS: Esophagogastroduodenoscopy and biopsy before and after the treatment course were made in 124 DU patients. Depending on timing of moor applications, pine and pearl baths, the patients were divided into 2 groups. Patients of group 1 received procedures daily with interval 4-5 hours (intensive course), patients of group 2 were treated each other day. RESULTS: 3-4 weeks of the treatment produced a response in both groups but in group 2 there were no signs of active inflammation in gastric and duodenum mucosa. 2 years later, patients of group 1 had histological evidence of chronic inflammation exacerbation. The latter was absent in group 2. CONCLUSION: An intensive course of peloidobalneotherapy results in attenuation of chronic gastroduodenal inflammation in DU patients.